Regeneron Pharmaceuticals, Inc...

NASDAQ: REGN
$582.52
-$3.22 (-0.5%)
Closing price October 27, 2020
The October 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Here are 13 other companies that should seriously entertain splitting their stocks. Splits are of course a gimmick, but the stock market usually rewards companies for splitting their stocks.
Earnings season is upon us and investors are pining for information about which stocks and sectors will do well. After all, many investors missed the bulk of the recovery from March’s panic...
The September 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Tuesday's top analyst upgrades and downgrades included Alexion Pharmaceuticals, Bill.com, Boeing, Costco, Dicks Sporting Goods, Generac, Proofpoint, Regeneron Pharmaceuticals and Shopify.
Many health care products become much more popular because of endorsements and advertising efforts. It is a longstanding practice that has come under fire by both political parties in the United...
Monday's top analyst upgrades and downgrades included American Express, AT&T, CRISPR Therapeutics, DocuSign, ONEOK, Regeneron Pharmaceuticals, Shopify and Tesla.
Moderna and Regeneron Pharmaceuticals each announced positive news late on Tuesday about their respective COVID-19 vaccine trials.
The September 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
As an approved COVID-19 vaccine nears completion in terms of clinical trials, what can we expect? In the past couple of weeks, firms working toward this goal have taken steps forward and back, which...
The August 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Practically any biotech company attempting almost anything COVID-19 related has seen massive gains. However, there is likely more to come for the rest of the year and into next year. These five...
After Friday's close, two very high-profile stock splits are taking place. 24/7 Wall St. thinks there are some other stocks that could and should split their shares in their wake.
The August 14 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Thursday's top analyst upgrades and downgrades included BioMarin Pharmaceuticals, Checkpoint Software Technologies, Cinemark, Fortinet, Palo Alto Networks, Regeneron Pharmaceuticals, Shake Shack,...